Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Clonal Evolution Under Therapy

Mel Greaves

PhD, FRS

🏢Institute of Cancer Research London🌐UK

Director of the Centre for Evolution and Cancer

110
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Mel Greaves is the founding father of the field of cancer evolution who established the Darwinian framework for understanding how cancers develop, progress, and resist treatment through clonal selection and evolutionary dynamics. His research at the Institute of Cancer Research has revealed the evolutionary trajectories of childhood leukemia, demonstrating that pre-leukemic clones arise in utero and undergo Darwinian selection over years before clinical presentation. His evolutionary perspective has profoundly influenced modern oncology and led to the development of evolutionary-informed therapeutic strategies.

Share:

🧪Research Fields 研究领域

Darwinian cancer evolution theory
Childhood leukemia evolution
Pre-leukemic clone dynamics
Evolutionary cancer prevention
Delayed infection leukemia hypothesis

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Mel Greaves 的研究动态

Follow Mel Greaves's research updates

留下邮箱,当我们发布与 Mel Greaves(Institute of Cancer Research London)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment